JCOG trials of systemic chemotherapy for unresectable or recurrent gastric cancer

Gastric Cancer

Volumn 12, Issue SUPPL. 1, 2009, Pages 43-49

  Boku, Narikazu ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Cisplatin; Fluoropyrimidine; Gastric cancer; Irinotecan; JCOG

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CAPECITABINE; CISPLATIN; DOXIFLURIDINE; DOXORUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; MITOMYCIN; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; TEGAFUR; UFT;

ADVANCED CANCER; ANOREXIA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIARRHEA; DRUG FATALITY; DRUG TREATMENT FAILURE; FATIGUE; FEBRILE NEUTROPENIA; HUMAN; HYPONATREMIA; INFECTION; LEUKOPENIA; LOW DRUG DOSE; MONOTHERAPY; NAUSEA; NEUTROPENIA; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STOMACH CANCER; STOMATITIS; TREATMENT RESPONSE;

EID: 65349100790     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-008-0467-6     Document Type: Review

References (29)

1. D.M. Parkin F. Bray J. Ferlay P. Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. A.M. Murad F.F. Santiago A. Petroianu P.R. Rocha M.A. Rodrigues M. Rausch 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41
3. B. Glimelius K. Hoffmann U. Haglund O. Nyren P.O. Sjoden 1994 Initial or delayed chemotherapy with best supportive care in advanced gastric cancer Ann Oncol 5 189 190
4. S. Pyrhonen T. Kuitumen P. Nyandoto M. Kouri 1995 Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus best supportive care alone in patients with nonresectable gastric cancer Br J Cancer 71 587 591
5. S.A. Cullinan C.G. Moertel T.R. Fleming J.E. Krook L.K. Everson H.E. Windschitl 1985 A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin, and mitomycin JAMA 253 2061 2067
6. J.A. Wils H.O. Klein D.J. Wagener H. Bleiberg H. Reis F. Korsten 1991 Sequential high-dose methotrexate and fluorouracil, combined with doxorubicin: a step ahead in the treatment of gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Co-operative Group J Clin Oncol 9 827 831
7. D. Kelsen O.T. Atiq L. Saltz D. Niedzwiecki D. Ginn D. Chapman 1992 FAMTX versus etoposide, doxorubicin and cisplatin: a randomized trial in gastric cancer J Clin Oncol 10 541 548
8. N.K. Kim Y.S. Park D.S. Heo C. Suh S.Y. Kim K.C. Park 1993 A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer 71 3813 3818
9. S.A. Cullinan C.G. Moertel H.S. Wieand M.J. O'Connel M.A. Poon J.E. Krook 1994 Controlled evaluation of three drug combination regimen versus fluorouracil alone in the therapy of advanced gastric cancer J Clin Oncol 12 412 416
10. G. Cocconi M. Bella S. Zironi R. Algeri F. Di Costanzo V. De Lisi 1994 Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research J Clin Oncol 12 2687 2693
11. A. Webb D. Cunningham J.H. Scarffe P. Harper A. Norman J.K. Joffe 1997 Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261 267
12. U. Vanhoefer P. Rougier H. Wilke M.P. Ducreux A.J. Lacave E. Van Cutsem 2000 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group J Clin Oncol 18 2648 2657
13. M. Kurihara T. Izumi S. Yoshida T. Ohkubo S. Suga 1991 A cooperative randomized study on tegafur plus mitomycin C in the treatment of advanced gastric cancer Jpn J Cancer Res 82 613 620
14. Y. Shimada S. Yoshida A. Ohtsu S. Seki H. Saito 1991 A phase II study of EAP (etoposide, adriamycin and cisplatin) in the patients with advanced gastric cancer: multi-institutional study (abstract) Annual Meeting Japan Society of Clinical Oncology 26 280
15. A. Ohtsu Y. Shimada S. Yoshida H. Saito S. Seki K. Morise 1994 Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG) Eur J Cancer 30A 2091 2093
16. A. Ohtsu Y. Shimada K. Shirao N. Boku I. Hyodo H. Saito 2003 Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 59
17. N. Boku A. Ohtsu Y. Shimada K. Shirao S. Seki H. Saito 1999 A phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319 323
18. Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
19. W. Koizumi M. Kurihara S. Nakano K. Hasegawa 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197
20. Boku N, Yamamoto S, Shirao K, Doi T, Sawaki A, Koizumi W, et al. Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). Annual meeting of ASCO, 2007; abstract LBA4513.
21. W. Koizumi H. Narahara T. Hara A. Takagane T. Akiya M. Takagi 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221
22. Imamura H, Iiishi H, Tsuburaya A, Hatake K, Imamoto H, Esaki T, et al. Randomized phase III study of irinotecan plus S-1 (IRIS) versus S-1 alone as first-line treatment for advanced gastric cancer (GC0301/TOP002). Gastrointestinal Cancers Symposium 2008:abstract 5.
23. T. Yamao Y. Shimada K. Shirao A. Ohtsu N. Ikeda I. Hyodo 2004 A phase II study of sequential methotrexate and 5-fluorouracil for advanced gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial Jpn J Clin 34 316 322
24. Y. Yamada A. Ohtsu N. Boku I. Hyodo H. Saitoh Y. Miyata 2001 Phase II trial of paclitaxel by 3-h infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions Ann Oncol 12 1133 1137
25. A. Sulkes J. Smyth C. Sessa L.Y. Dirix J.B. Vermoken S. Kaye 1994 Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group Br J Cancer 70 380 383
26. S. Hironaka S. Zenda N. Boku A. Fukutomi T. Yoshino Y. Onozawa 2006 Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer Gastric Cancer 9 14 18
27. S. Ueda S. Hironaka N. Boku A. Fukutomi T. Yoshino Y. Onozawa 2006 Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer Gastric Cancer 9 203 207
28. T. Hamaguchi K. Shirao N. Yamamichi I. Hyodo W. Koizumi S. Seki 2008 A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 Trial Jpn J Clin Oncol 38 432 437
29. N. Ikeda Y. Shimada A. Ohtsu N. Boku Y. Tsuji H. Saito 2002 A phase II study of doxifluridine in elderly patients with advanced gastric cancer: Japan Clinical Oncology Group Study (JCOG9410) Jpn J Clin Oncol 32 90 94